NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $0.62 +0.01 (+1.64%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.60▼$0.6450-Day Range$0.45▼$0.6452-Week Range$0.44▼$2.94Volume127,758 shsAverage Volume383,877 shsMarket Capitalization$196.11 millionP/E RatioN/ADividend YieldN/APrice Target$4.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get P3 Health Partners alerts: Email Address P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside665.6% Upside$4.75 Price TargetShort InterestHealthy1.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.28) to ($0.27) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.43 out of 5 starsMedical Sector543rd out of 936 stocksHealth Services Industry5th out of 11 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.87% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 33.87%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 2.8 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.28) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesJuly 24 at 9:34 AM | finance.yahoo.comP3 Health Partners Schedules Second Quarter 2024 Earnings Release and Conference CallMay 28, 2024 | businesswire.comP3 Health Partners to Present at Upcoming Investor ConferencesJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 28, 2024 | investorplace.comWhy Is P3 Health Partners (PIII) Stock Down 4% Today?May 23, 2024 | businesswire.comP3 Health Partners Inc. Announces Approximately $42.2 Million Private PlacementMay 12, 2024 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q1 2024 Earnings Call TranscriptMay 9, 2024 | businesswire.comP3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2024 | finance.yahoo.comP3 Health Partners Announces First Quarter 2024 ResultsJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 8, 2024 | finance.yahoo.comP3 Health Partners Names Dr. Aric Coffman as CEOMay 2, 2024 | businesswire.comP3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference CallApril 3, 2024 | businesswire.comP3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 28, 2024 | benzinga.comP3 Health Partners: Q4 Earnings InsightsMarch 28, 2024 | finance.yahoo.comP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net LossMarch 28, 2024 | businesswire.comP3 Health Partners Announces Fourth Quarter and Full Year 2023 ResultsMarch 17, 2024 | uk.investing.comP3 Health to report Q4 and full year 2023 earnings on March 28February 28, 2024 | businesswire.comP3 Health Partners to Participate in the Jefferies Value Based Healthcare SummitFebruary 19, 2024 | businesswire.comP3 Health Partners to Present at the TD Cowen 44th Annual Healthcare ConferenceSee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Next Earnings (Confirmed)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Stock Price Target$4.75 High Stock Price Target$5.00 Low Stock Price Target$4.50 Potential Upside/Downside+691.0%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-4.97% Pretax Margin-13.24% Return on Equity-79.03% Return on Assets-7.64% Debt Debt-to-Equity Ratio0.81 Current Ratio0.55 Quick Ratio0.55 Sales & Book Value Annual Sales$1.27 billion Price / Sales0.15 Cash Flow$0.10 per share Price / Cash Flow6.26 Book Value$0.45 per share Price / Book1.33Miscellaneous Outstanding Shares316,110,000Free Float259,657,000Market Cap$189.82 million OptionableNot Optionable Beta1.19 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 63)FACP, M.D., Co-Founder, Director & Strategic Advisor Comp: $1.04MDr. Amir Bacchus M.B.A. (Age 59)M.D., Co-Founder, Chief Medical Officer & Director Comp: $780kMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyRoy YoungbloodDirector of ComplianceLeslie P. FisherSenior VP of Legal Affairs, General Counsel & Corporate SecretaryMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMr. Todd Lefkowitz MHAChief Managed Care OfficerMs. Sarah Bussmann B.S.N.CRNI, M.H.A., R.N., Chief of StaffMore ExecutivesKey CompetitorsGlobal Consumer AcquisitionNASDAQ:GACQOrion Biotech OpportunitiesNASDAQ:ORIAInternational Media AcquisitionNASDAQ:IMAQFrontier InvestmentNASDAQ:FICVbleuacaciaNASDAQ:BLEUView All CompetitorsInsiders & InstitutionsSanders Morris Harris LLCBought 20,000 shares on 7/12/2024Ownership: 0.045%Janus Henderson Group PLCSold 1,666,788 shares on 5/16/2024Ownership: 0.670%GSA Capital Partners LLPBought 296,936 shares on 5/3/2024Ownership: 0.179%Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/13/2023Total: $238,500.00 ($2.65/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/11/2023Total: $210,600.00 ($2.34/share)View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $1.41 at the beginning of the year. Since then, PIII shares have decreased by 56.0% and is now trading at $0.6204. View the best growth stocks for 2024 here. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) posted its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.03. The company earned $388.49 million during the quarter, compared to analyst estimates of $352 million. P3 Health Partners had a negative trailing twelve-month return on equity of 79.03% and a negative net margin of 4.97%. Who are P3 Health Partners' major shareholders? P3 Health Partners' top institutional shareholders include Sanders Morris Harris LLC (0.05%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou, Atul Kavthekar and Michael Balkin. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
